OA group developed arterial hypertension (p = 0.0003) and hyperlipidemia (p = 0.04) and, consequently, were treated with β blockers (p = 0.004) and angiotensin-converting enzyme inhibitors (ACEI) (p = 0.004) more frequently than RA sufferers. The gene discussed is ACE; the disease is hyperlipidemia.